Cholesterol Lowering and Prevention of Stroke

Daniel G Hackam^{1

2}, Robert A Hegele^{3

4}

Affiliations

¹ From the Division of Clinical Pharmacology, Department of Medicine (D.G.H.), Western University, London, Ontario, Canada.
² Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute (D.G.H.), Western University, London, Ontario, Canada.
³ Division of Endocrinology and Metabolism, Department of Medicine (R.A.H.), Western University, London, Ontario, Canada.
⁴ Molecular Medicine Research Laboratories, Robarts Research Institute (R.A.H.), Western University, London, Ontario, Canada.

Review

Daniel G Hackam et al. Stroke. 2019 Feb.

. 2019 Feb;50(2):537-541.

doi: 10.1161/STROKEAHA.118.023167.

Daniel G Hackam^{1

2}, Robert A Hegele^{3

4}

¹ From the Division of Clinical Pharmacology, Department of Medicine (D.G.H.), Western University, London, Ontario, Canada.
² Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute (D.G.H.), Western University, London, Ontario, Canada.
³ Division of Endocrinology and Metabolism, Department of Medicine (R.A.H.), Western University, London, Ontario, Canada.
⁴ Molecular Medicine Research Laboratories, Robarts Research Institute (R.A.H.), Western University, London, Ontario, Canada.

No abstract available

Keywords: cholesterol; clinical trials as topic; niacin; risk factors; stroke.

Publication types